137 related articles for article (PubMed ID: 38303543)
1.
Machado I; Zhang Y; Hameed M; Hwang S; Sharma AE; Bilsky MH; Linos K
Int J Surg Pathol; 2024 Feb; ():10668969241229345. PubMed ID: 38303543
[TBL] [Abstract][Full Text] [Related]
2. GRM1 Immunohistochemistry Distinguishes Chondromyxoid Fibroma From its Histologic Mimics.
Toland AMS; Lam SW; Varma S; Wang A; Howitt BE; Kunder CA; Kerr DA; Szuhai K; Bovée JVMG; Charville GW
Am J Surg Pathol; 2022 Oct; 46(10):1407-1414. PubMed ID: 35650682
[TBL] [Abstract][Full Text] [Related]
3. Cytopathology of Chondromyxoid Fibroma: Report of 2 Cases with Immunocytochemical Expression of GRM1.
Watabe S; Kikuchi Y; Motoi T; Yamamoto A; Imanishi J; Tokizaki T; Sato K; Mukaiyama J; Minami S; Ishida T; Kawano H; Uozaki H
Acta Cytol; 2024; 68(1):66-72. PubMed ID: 38281480
[TBL] [Abstract][Full Text] [Related]
4. Phosphaturic mesenchymal tumor: A chondromyxoid fibroma-like type.
Koga K; Iwasaki H; Nabeshima K
J Dermatol; 2023 Nov; 50(11):1484-1487. PubMed ID: 37350024
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous chondromyxoid fibroma with a novel PNISR::GRM1 fusion-report of a primary soft tissue tumour without connection to an underlying bone.
Zupan A; Salapura V; Šekoranja D; Pižem J
Virchows Arch; 2023 May; 482(5):917-921. PubMed ID: 36810795
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant.
Shiba E; Matsuyama A; Shibuya R; Yabuki K; Harada H; Nakamoto M; Kasai T; Hisaoka M
Diagn Pathol; 2016 Mar; 11():26. PubMed ID: 26956379
[TBL] [Abstract][Full Text] [Related]
7. A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors.
Carter JM; Caron BL; Dogan A; Folpe AL
Am J Surg Pathol; 2015 Jan; 39(1):75-83. PubMed ID: 25025444
[TBL] [Abstract][Full Text] [Related]
8. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia.
Bahrami A; Weiss SW; Montgomery E; Horvai AE; Jin L; Inwards CY; Folpe AL
Am J Surg Pathol; 2009 Sep; 33(9):1348-54. PubMed ID: 19609206
[TBL] [Abstract][Full Text] [Related]
9. Aberrations of 6q13 mapped to the COL12A1 locus in chondromyxoid fibroma.
Yasuda T; Nishio J; Sumegi J; Kapels KM; Althof PA; Sawyer JR; Reith JD; Bridge JA
Mod Pathol; 2009 Nov; 22(11):1499-506. PubMed ID: 19648885
[TBL] [Abstract][Full Text] [Related]
10. GRM1 is upregulated through gene fusion and promoter swapping in chondromyxoid fibroma.
Nord KH; Lilljebjörn H; Vezzi F; Nilsson J; Magnusson L; Tayebwa J; de Jong D; Bovée JV; Hogendoorn PC; Szuhai K
Nat Genet; 2014 May; 46(5):474-7. PubMed ID: 24658000
[TBL] [Abstract][Full Text] [Related]
11. The pericentromeric inversion, inv (6)(p25q13), is a novel diagnostic marker in chondromyxoid fibroma.
Granter SR; Renshaw AA; Kozakewich HP; Fletcher JA
Mod Pathol; 1998 Nov; 11(11):1071-4. PubMed ID: 9831204
[TBL] [Abstract][Full Text] [Related]
12. Cytopathology of chondromyxoid fibroma: a case series and review of the literature.
Wangsiricharoen S; Wakely PE; Siddiqui MT; Ali SZ
J Am Soc Cytopathol; 2021; 10(4):366-381. PubMed ID: 33958292
[TBL] [Abstract][Full Text] [Related]
13. Chondromyxoid Fibroma of Distal Phalanx of the Great Toe: A Rare Clinical Entity.
Vasudeva N; Shyam Kumar C; Ayyappa Naidu CR
Cureus; 2020 Feb; 12(2):e7133. PubMed ID: 32257678
[TBL] [Abstract][Full Text] [Related]
14. A Case Report of Chondromyxoid Fibroma of the Nasal Cavity.
Kaur J; Aggarwal A; Yadav V; Bhagat S; Sharma D
Indian J Otolaryngol Head Neck Surg; 2023 Dec; 75(4):3975-3979. PubMed ID: 37974817
[TBL] [Abstract][Full Text] [Related]
15. Recurrent chondromyxoid fibroma of the distal femur treated with percutaneous cryoablation.
Gowda PC; Dunlap RH; Ahlawat S; Gross JM; Morris CD; Lyons GR
Skeletal Radiol; 2023 Dec; 52(12):2497-2501. PubMed ID: 37544967
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic diversity in chondromyxoid fibroma reveals differentiation pattern of tumor mimicking fetal cartilage canals development: an immunohistochemical study.
Zustin J; Akpalo H; Gambarotti M; Priemel M; Rueger JM; Luebke AM; Reske D; Lange C; Pueschel K; Lohmann C; Rüther W; Amling M; Alberghini M
Am J Pathol; 2010 Sep; 177(3):1072-8. PubMed ID: 20671262
[TBL] [Abstract][Full Text] [Related]
17. Chondromyxoid Fibroma of the Sacral Spine.
Dodson V; Majmundar N; Sharer L; Fitzhugh VA; Assina R
Int J Surg Pathol; 2020 Oct; 28(7):799-803. PubMed ID: 32362154
[No Abstract] [Full Text] [Related]
18. Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum.
Agaimy A; Michal M; Chiosea S; Petersson F; Hadravsky L; Kristiansen G; Horch RE; Schmolders J; Hartmann A; Haller F; Michal M
Am J Surg Pathol; 2017 Oct; 41(10):1371-1380. PubMed ID: 28614212
[TBL] [Abstract][Full Text] [Related]
19. Cell biology and matrix biochemistry of chondromyxoid fibroma.
Söder S; Inwards C; Müller S; Kirchner T; Aigner T
Am J Clin Pathol; 2001 Aug; 116(2):271-7. PubMed ID: 11488075
[TBL] [Abstract][Full Text] [Related]
20. Pseudotetraploid clone with structural chromosomal rearrangements in a chondromyxoid fibroma: a case report.
Liu J; Ownbey RT; Boc SF; Pezanowski DM; Patel DM; Sadri S; Vincent GA; de Chadarévian JP
Pediatr Dev Pathol; 2013; 16(3):201-5. PubMed ID: 23282218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
